Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 94

Published Date: 05 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Influenza Vaccine size is estimated to be XX million in 2021 from USD 5303.2 million in 2020, with a change of XX% between 2020 and 2021. The global Influenza Vaccine market size is expected to grow at a CAGR of 3.6% for the next five years.

Market segmentation
Influenza Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

Market segment by Application can be divided into
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

The key market players for global Influenza Vaccine market are listed below:
    CSL
    GSK
    Sanofi Pasteur
    Mylan
    Hulan Bio
    AstraZeneca
    CCBIO

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Influenza Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenza Vaccine, with price, sales, revenue and global market share of Influenza Vaccine from 2019 to 2021.
Chapter 3, the Influenza Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Influenza Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Influenza Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Influenza Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Global Influenza Vaccine Market Size & Forecast
        1.4.1 Global Influenza Vaccine Sales in Value (2016-2026))
        1.4.2 Global Influenza Vaccine Sales in Volume (2016-2026)
        1.4.3 Global Influenza Vaccine Price by Type (2016-2026) & (USD/Doses)
    1.5 Global Influenza Vaccine Production Capacity Analysis
        1.5.1 Global Influenza Vaccine Total Production Capacity (2016-2026)
        1.5.2 Global Influenza Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Influenza Vaccine Market Drivers
        1.6.2 Influenza Vaccine Market Restraints
        1.6.3 Influenza Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 CSL
        2.1.1 CSL Details
        2.1.2 CSL Major Business
        2.1.3 CSL Influenza Vaccine Product and Services
        2.1.4 CSL Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Influenza Vaccine Product and Services
        2.2.4 GSK Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Sanofi Pasteur
        2.3.1 Sanofi Pasteur Details
        2.3.2 Sanofi Pasteur Major Business
        2.3.3 Sanofi Pasteur Influenza Vaccine Product and Services
        2.3.4 Sanofi Pasteur Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Mylan
        2.4.1 Mylan Details
        2.4.2 Mylan Major Business
        2.4.3 Mylan Influenza Vaccine Product and Services
        2.4.4 Mylan Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Hulan Bio
        2.5.1 Hulan Bio Details
        2.5.2 Hulan Bio Major Business
        2.5.3 Hulan Bio Influenza Vaccine Product and Services
        2.5.4 Hulan Bio Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 AstraZeneca
        2.6.1 AstraZeneca Details
        2.6.2 AstraZeneca Major Business
        2.6.3 AstraZeneca Influenza Vaccine Product and Services
        2.6.4 AstraZeneca Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 CCBIO
        2.7.1 CCBIO Details
        2.7.2 CCBIO Major Business
        2.7.3 CCBIO Influenza Vaccine Product and Services
        2.7.4 CCBIO Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Influenza Vaccine Sales by Manufacturer
    3.1 Global Influenza Vaccine Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Influenza Vaccine Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Influenza Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Influenza Vaccine Manufacturer Market Share
        3.4.2 Top 6 Influenza Vaccine Manufacturer Market Share
    3.5 Global Influenza Vaccine Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Influenza Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Influenza Vaccine Market Size by Region
        4.1.1 Global Influenza Vaccine Sales in Volume by Region (2016-2026)
        4.1.2 Global Influenza Vaccine Revenue by Region (2016-2026)
    4.2 North America Influenza Vaccine Revenue (2016-2026)
    4.3 Europe Influenza Vaccine Revenue (2016-2026)
    4.4 Asia-Pacific Influenza Vaccine Revenue (2016-2026)
    4.5 South America Influenza Vaccine Revenue (2016-2026)
    4.6 Middle East and Africa Influenza Vaccine Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Influenza Vaccine Sales in Volume by Type (2016-2026)
    5.2 Global Influenza Vaccine Revenue by Type (2016-2026)
    5.3 Global Influenza Vaccine Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Influenza Vaccine Sales in Volume by Application (2016-2026)
    6.2 Global Influenza Vaccine Revenue by Application (2016-2026)
    6.3 Global Influenza Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Influenza Vaccine Sales by Type (2016-2026)
    7.2 North America Influenza Vaccine Sales by Application (2016-2026)
    7.3 North America Influenza Vaccine Market Size by Country
        7.3.1 North America Influenza Vaccine Sales in Volume by Country (2016-2026)
        7.3.2 North America Influenza Vaccine Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Influenza Vaccine Sales by Type (2016-2026)
    8.2 Europe Influenza Vaccine Sales by Application (2016-2026)
    8.3 Europe Influenza Vaccine Market Size by Country
        8.3.1 Europe Influenza Vaccine Sales in Volume by Country (2016-2026)
        8.3.2 Europe Influenza Vaccine Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Influenza Vaccine Sales by Type (2016-2026)
    9.2 Asia-Pacific Influenza Vaccine Sales by Application (2016-2026)
    9.3 Asia-Pacific Influenza Vaccine Market Size by Region
        9.3.1 Asia-Pacific Influenza Vaccine Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Influenza Vaccine Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Influenza Vaccine Sales by Type (2016-2026)
    10.2 South America Influenza Vaccine Sales by Application (2016-2026)
    10.3 South America Influenza Vaccine Market Size by Country
        10.3.1 South America Influenza Vaccine Sales in Volume by Country (2016-2026)
        10.3.2 South America Influenza Vaccine Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Influenza Vaccine Sales by Type (2016-2026)
    11.2 Middle East & Africa Influenza Vaccine Sales by Application (2016-2026)
    11.3 Middle East & Africa Influenza Vaccine Market Size by Country
        11.3.1 Middle East & Africa Influenza Vaccine Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Influenza Vaccine Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Influenza Vaccine Typical Distributors
    12.3 Influenza Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Influenza Vaccine Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Influenza Vaccine Revenue by Application, (USD Million), 2021-2026
    Table 3. CSL Basic Information, Manufacturing Base and Competitors
    Table 4. CSL Major Business
    Table 5. CSL Influenza Vaccine Product and Services
    Table 6. CSL Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. GSK Basic Information, Manufacturing Base and Competitors
    Table 8. GSK Major Business
    Table 9. GSK Influenza Vaccine Product and Services
    Table 10. GSK Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
    Table 12. Sanofi Pasteur Major Business
    Table 13. Sanofi Pasteur Influenza Vaccine Product and Services
    Table 14. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Mylan Basic Information, Manufacturing Base and Competitors
    Table 16. Mylan Major Business
    Table 17. Mylan Influenza Vaccine Product and Services
    Table 18. Mylan Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Hulan Bio Basic Information, Manufacturing Base and Competitors
    Table 20. Hulan Bio Major Business
    Table 21. Hulan Bio Influenza Vaccine Product and Services
    Table 22. Hulan Bio Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 24. AstraZeneca Major Business
    Table 25. AstraZeneca Influenza Vaccine Product and Services
    Table 26. AstraZeneca Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. CCBIO Basic Information, Manufacturing Base and Competitors
    Table 28. CCBIO Major Business
    Table 29. CCBIO Influenza Vaccine Product and Services
    Table 30. CCBIO Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Global Influenza Vaccine Sales by Manufacturer (2019-2021e) & (M Doses)
    Table 32. Global Influenza Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 33. Market Position of Manufacturers in Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 34. Global Influenza Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
    Table 35. Head Office and Influenza Vaccine Production Site of Key Manufacturer
    Table 36. Influenza Vaccine New Entrant and Capacity Expansion Plans
    Table 37. Influenza Vaccine Mergers & Acquisitions in the Past Five Years
    Table 38. Global Influenza Vaccine Sales by Region (2016-2021e) & (M Doses)
    Table 39. Global Influenza Vaccine Sales by Region (2021-2026) & (M Doses)
    Table 40. Global Influenza Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 41. Global Influenza Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 42. Global Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 43. Global Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 44. Global Influenza Vaccine Revenue by Type (2016-2021e) & (USD Million)
    Table 45. Global Influenza Vaccine Revenue by Type (2021-2026) & (USD Million)
    Table 46. Global Influenza Vaccine Price by Type (2016-2021e) & (USD/Doses)
    Table 47. Global Influenza Vaccine Price by Type (2021-2026) & (USD/Doses)
    Table 48. Global Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 49. Global Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 50. Global Influenza Vaccine Revenue by Application (2016-2021e) & (USD Million)
    Table 51. Global Influenza Vaccine Revenue by Application (2021-2026) & (USD Million)
    Table 52. Global Influenza Vaccine Price by Application (2016-2021e) & (USD/Doses)
    Table 53. Global Influenza Vaccine Price by Application (2021-2026) & (USD/Doses)
    Table 54. North America Influenza Vaccine Sales by Country (2016-2021e) & (M Doses)
    Table 55. North America Influenza Vaccine Sales by Country (2021-2026) & (M Doses)
    Table 56. North America Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 57. North America Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 58. North America Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 59. North America Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 60. North America Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 61. North America Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 62. Europe Influenza Vaccine Sales by Country (2016-2021e) & (M Doses)
    Table 63. Europe Influenza Vaccine Sales by Country (2021-2026) & (M Doses)
    Table 64. Europe Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 65. Europe Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 66. Europe Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 67. Europe Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 68. Europe Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 69. Europe Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 70. Asia-Pacific Influenza Vaccine Sales by Region (2016-2021e) & (M Doses)
    Table 71. Asia-Pacific Influenza Vaccine Sales by Region (2021-2026) & (M Doses)
    Table 72. Asia-Pacific Influenza Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 73. Asia-Pacific Influenza Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 74. Asia-Pacific Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 75. Asia-Pacific Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 76. Asia-Pacific Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 77. Asia-Pacific Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 78. South America Influenza Vaccine Sales by Country (2016-2021e) & (M Doses)
    Table 79. South America Influenza Vaccine Sales by Country (2021-2026) & (M Doses)
    Table 80. South America Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 81. South America Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 82. South America Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 83. South America Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 84. South America Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 85. South America Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 86. Middle East & Africa Influenza Vaccine Sales by Country (2016-2021e) & (M Doses)
    Table 87. Middle East & Africa Influenza Vaccine Sales by Country (2021-2026) & (M Doses)
    Table 88. Middle East & Africa Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 89. Middle East & Africa Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 90. Middle East & Africa Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 91. Middle East & Africa Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 92. Middle East & Africa Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 93. Middle East & Africa Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 94. Direct Channel Pros & Cons
    Table 95. Indirect Channel Pros & Cons
    Table 96. Influenza Vaccine Typical Distributors
    Table 97. Influenza Vaccine Typical Customers
List of Figures
    Figure 1. Influenza Vaccine Picture
    Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2020
    Figure 3. Trivalent Influenza Vaccine
    Figure 4. Quadrivalent Influenza Vaccine
    Figure 5. Global Influenza Vaccine Sales Market Share by Application in 2020
    Figure 6. For Children (6 months to 3 years)
    Figure 7. For Adults and Children over 3 years
    Figure 8. Global Influenza Vaccine Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
    Figure 9. Global Influenza Vaccine Market Size and Forecast (2016-2026) & (USD Million)
    Figure 10. Global Influenza Vaccine Sales (2016-2026) & (M Doses)
    Figure 11. Global Influenza Vaccine Price by Type (2016-2026) & (USD/Doses)
    Figure 12. Global Influenza Vaccine Production Capacity (2016-2026) & (M Doses)
    Figure 13. Global Influenza Vaccine Production Capacity by Geographic Region: 2020 VS 2021
    Figure 14. Influenza Vaccine Market Drivers
    Figure 15. Influenza Vaccine Market Restraints
    Figure 16. Influenza Vaccine Market Trends
    Figure 17. Global Influenza Vaccine Sales Market Share by Manufacturer in 2020
    Figure 18. Global Influenza Vaccine Revenue Market Share by Manufacturer in 2020
    Figure 19. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 20. Top 3 Influenza Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 21. Top 6 Influenza Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 22. Global Influenza Vaccine Sales Market Share by Region (2016-2026)
    Figure 23. Global Influenza Vaccine Revenue Market Share by Region (2016-2026)
    Figure 24. North America Influenza Vaccine Revenue (2016-2026) & (USD Million)
    Figure 25. Europe Influenza Vaccine Revenue (2016-2026) & (USD Million)
    Figure 26. Asia-Pacific Influenza Vaccine Revenue (2016-2026) & (USD Million)
    Figure 27. South America Influenza Vaccine Revenue (2016-2026) & (USD Million)
    Figure 28. Middle East & Africa Influenza Vaccine Revenue (2016-2026) & (USD Million)
    Figure 29. Global Influenza Vaccine Sales Market Share by Type (2016-2026)
    Figure 30. Global Influenza Vaccine Revenue Market Share by Type (2016-2026)
    Figure 31. Global Influenza Vaccine Price by Type (2016-2026) & (USD/Doses)
    Figure 32. Global Influenza Vaccine Sales Market Share by Application (2016-2026)
    Figure 33. Global Influenza Vaccine Revenue Market Share by Application (2016-2026)
    Figure 34. Global Influenza Vaccine Price by Application (2016-2026) & (USD/Doses)
    Figure 35. North America Influenza Vaccine Sales Market Share by Type (2016-2026)
    Figure 36. North America Influenza Vaccine Sales Market Share by Application (2016-2026)
    Figure 37. North America Influenza Vaccine Sales Market Share by Country (2016-2026)
    Figure 38. North America Influenza Vaccine Revenue Market Share by Country (2016-2026)
    Figure 39. United States Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 40. Canada Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Mexico Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Europe Influenza Vaccine Sales Market Share by Type (2016-2026)
    Figure 43. Europe Influenza Vaccine Sales Market Share by Application (2016-2026)
    Figure 44. Europe Influenza Vaccine Sales Market Share by Country (2016-2026)
    Figure 45. Europe Influenza Vaccine Revenue Market Share by Country (2016-2026)
    Figure 46. Germany Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. France Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. United Kingdom Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Russia Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Italy Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2016-2026)
    Figure 52. Asia-Pacific Influenza Vaccine Sales Market Share by Application (2016-2026)
    Figure 53. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2016-2026)
    Figure 54. Asia-Pacific Influenza Vaccine Revenue Market Share by Region (2016-2026)
    Figure 55. China Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Japan Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Korea Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. India Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Southeast Asia Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Australia Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. South America Influenza Vaccine Sales Market Share by Type (2016-2026)
    Figure 62. South America Influenza Vaccine Sales Market Share by Application (2016-2026)
    Figure 63. South America Influenza Vaccine Sales Market Share by Country (2016-2026)
    Figure 64. South America Influenza Vaccine Revenue Market Share by Country (2016-2026)
    Figure 65. Brazil Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Argentina Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2016-2026)
    Figure 68. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2016-2026)
    Figure 69. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2016-2026)
    Figure 70. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2016-2026)
    Figure 71. Turkey Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Egypt Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Saudi Arabia Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. South Africa Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Sales Channel: Direct Channel vs Indirect Channel
    Figure 76. Methodology
    Figure 77. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CSL
GSK
Sanofi Pasteur
Mylan
Hulan Bio
AstraZeneca
CCBIO

Related Reports

Global Influenza Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Influenza Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 25 May 2022

date Pharma & Healthcare

The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Oct 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Influenza Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.

Global Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Global Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

date 18 Oct 2023

date Pharma & Healthcare

The global Influenza Vaccine market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).

Product Tags

influenza vaccine

flu influenza vaccine

pandemic influenza vaccine

nasal spray influenza vaccine

children influenza vaccine

canine influenza vaccine

equine influenza vaccine

needle free influenza vaccine

inhaled nasal influenza vaccine

inactivated influenza vaccine

injection influenza vaccine

live attenuated influenza vaccine laiv

trivalent inactivated influenza vaccine

Needle-Free Influenza Vaccine

Flu (Influenza) Vaccine

Nasal Spray Live Attenuated Influenza Vaccine

Live Attenuated Influenza Vaccine (LAIV)

Split Influenza Vaccine

Adjuvanted Influenza Vaccine

Recombinant Influenza Vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>